WMSA
HRMY icon

Weiss Multi-Strategy Advisers’s Harmony Biosciences HRMY Stock Holding History

Weiss Multi-Strategy Advisers’s Portfolio HRMY Stock Details HRMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-10,015
Closed -$352K – 617
2023
Q2 		$352K Sell
10,015
-24,985
-71% -$863K 0.01% 589
2023
Q1 		$1.14M Buy
+35,000
New +$1.59M 0.03% 498

Other funds holding HRMY

VM
Valor Management Chicago, Illinois $181M AUM 6.67% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VP
venBio Partners San Francisco, California $281M AUM 261.03% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

Weiss Multi-Strategy Advisers's HRMY Position: Q3 2023 in Review

Weiss Multi-Strategy Advisers sold out of Harmony Biosciences (HRMY) in Q3 2023, closing a stake of 10,015 shares — an estimated $352K sold.

Weiss Multi-Strategy Advisers first reported a position in HRMY in Q1 2023 and held it in 2 quarters. The position peaked at $1.14M in Q1 2023. 204 funds tracked by Wall St. Rank hold HRMY as of Q3 2023.

  • Weiss Multi-Strategy Advisers reported no remaining Harmony Biosciences position as of Q3 2023 after selling out during the quarter.
  • Weiss Multi-Strategy Advisers sold 10,015 Harmony Biosciences shares in Q3 2023, an estimated $352K.
  • Weiss Multi-Strategy Advisers first reported a position in Harmony Biosciences in Q1 2023 and held it in 2 quarters.
  • Weiss Multi-Strategy Advisers's Harmony Biosciences position peaked at $1.14M in Q1 2023.
  • 204 funds tracked by Wall St. Rank held Harmony Biosciences as of Q3 2023.

Based on Weiss Multi-Strategy Advisers's 13F filing for Q3 2023, filed 14 Nov 2023.